High street pharmacies across England will begin offering a free, seven-minute cholesterol test this autumn as part of a National Health Service initiative to combat deaths from heart attacks and strokes. The finger-prick blood test is designed to identify individuals with high cholesterol, a condition often referred to as a 'silent killer' because it has no noticeable symptoms.
Around six in ten adults in England have high cholesterol, which occurs when excessive fatty plaque builds up in the blood, potentially blocking arteries and leading to serious cardiovascular events. It is estimated that 170,000 deaths annually in the UK are attributed to heart attacks and strokes. Health officials hope this new testing program can reduce such fatalities by a quarter over the next decade.
Eligible individuals for the test include adults between the ages of 40 and 84 who have not had a blood test from the NHS in the past year. The test involves a small lancet prick to the finger, with results analyzed immediately. Following the test, prescribing pharmacists will provide lifestyle advice and determine if treatments, such as statins, are necessary. Patients will also receive their results via email and be offered a blood pressure check.
Dr. Rani Khatib, an NHS adviser on heart disease prevention, stated that the program will enable people to manage their risk factors earlier. David Webb, chief pharmaceutical officer for NHS England, added that the initiative makes it easier for people to receive quick health checks in their local communities, calling it an expansion of care previously only available in GP surgeries.
The scheme, which was unveiled at the European Society of Cardiology's annual congress in Munich, is set to launch this autumn with approximately 100 pharmacies participating in the initial six months. While specific rollout dates and pharmacy locations have not yet been announced, the services will be distributed across England.
This national rollout follows a successful pilot at Barts Health NHS Trust in London, where about 2,500 patients were tested. One in five participants in the pilot were identified as being at high risk of heart attack or stroke within the next decade. As a result, 88 individuals began statin treatment, and others were referred for further medical care or given lifestyle guidance.
Dr. Sotiris Antoniou, clinical lead for the scheme at Barts Health NHS Trust, highlighted the potential for this approach to improve patient outcomes and reduce health inequalities, particularly in communities with a high burden of cardiovascular disease. Health minister Alison McGovern emphasized that such early detection innovations are crucial for preventing serious conditions, keeping people healthier longer, and alleviating pressure on NHS services.